Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/21/1996 | WO1996030042A3 Methods of treating inflammation and compositions therefor |
11/21/1996 | WO1996029605A3 Compounds and methods for the dectection of t. cruzi infection |
11/21/1996 | WO1996029407A3 Cellubrevin homologs |
11/21/1996 | DE19517020A1 Niedermolekularer Wirkstoffextrakt aus Hefen und Verfahren zu seiner Herstellung Low molecular weight substance extract from yeasts and process for its preparation |
11/21/1996 | CA2227326A1 Carbohydrate-mediated coupling of peptides to immunoglobulins |
11/21/1996 | CA2221348A1 Transcriptional control sequences and methods |
11/21/1996 | CA2221305A1 Gene therapy for effector cell regulation |
11/21/1996 | CA2221303A1 Obesity gene product |
11/21/1996 | CA2221269A1 Compositions containing nucleic acids and ligands for therapeutic treatment |
11/21/1996 | CA2221232A1 Post-translational activation of tgf-.beta.1 involving the tsp-1 receptor cd36 |
11/21/1996 | CA2220674A1 Leptospira membrane proteins |
11/21/1996 | CA2220010A1 Bmp-15 compositions |
11/21/1996 | CA2219984A1 Cell death protein |
11/21/1996 | CA2219487A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
11/21/1996 | CA2217969A1 Ataxia-telangiectasia gene and its genomic organization |
11/21/1996 | CA2217965A1 Ataxia-telangiectasia gene |
11/21/1996 | CA2217020A1 Recombinant heregulins and their biological functions upon receptor activation |
11/20/1996 | EP0743522A1 Stabilised troponin composition for immunoassays and method for preparing such stabilised compositions |
11/20/1996 | EP0743520A2 Novel uses for GAL4-receptor constructs |
11/20/1996 | EP0743365A2 Process for efficiently producing transglutaminase through DNA recombination |
11/20/1996 | EP0743364A2 Nucleic acid fragments derived form the HIV-1 genome, corresponding fragments and their application as reactives for risk evaluation of HIV-1 mother-foetal transmission |
11/20/1996 | EP0743321A2 Obesity gene product |
11/20/1996 | EP0742903A1 Piperidine analogs and conjugates of procainamide and napa |
11/20/1996 | EP0742902A1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
11/20/1996 | EP0742831A1 Transgenic non-human mammals with progressive neurologic disease |
11/20/1996 | EP0742830A1 Fusion proteins that include antibody and nonantibody portions |
11/20/1996 | EP0742829A1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters |
11/20/1996 | EP0742826A1 Multivariant il-3 hematopoiesis fusion protein |
11/20/1996 | EP0742825A1 Cloning and recombinant production of crf receptor(s) |
11/20/1996 | EP0742824A1 Wd-40-derived peptides and uses thereof |
11/20/1996 | EP0742823A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions |
11/20/1996 | EP0742822A1 Folding proteins |
11/20/1996 | EP0742820A1 Production of pharmaceutical-grade plasmid dna |
11/20/1996 | EP0742796A1 Il-3 variant hematopoiesis fusion protein |
11/20/1996 | EP0742795A1 Immuno-stimulatory monoclonal antibodies |
11/20/1996 | EP0742794A1 Interleukin-6 (il-6) antagonists |
11/20/1996 | EP0742793A1 Bcl-2-associated proteins |
11/20/1996 | EP0742792A1 Subunits of glutamate receptors, method for producing them and their use |
11/20/1996 | EP0742790A1 Substituted purines and oligonucleotide cross-linking |
11/20/1996 | EP0742723A1 Homologous recombination for universal donor cells and chimeric mammalian hosts |
11/20/1996 | EP0742721A1 Methods of prolonged suppression of humoral immunity |
11/20/1996 | EP0742720A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production |
11/20/1996 | EP0656783B1 Pharmaceuticals containing onconase and cisplatin, melphalan and adriamycin |
11/20/1996 | EP0542895B1 Cross-reactive influenza a immunization |
11/20/1996 | EP0517895B1 Chimeric chains for receptor-associated signal transduction pathways |
11/20/1996 | EP0479916B1 Gamma retinoic acid receptor |
11/20/1996 | EP0439535B1 Cdnas coding for the gamma subunit of the high-affinity receptor for immunoglobulin e |
11/20/1996 | EP0430968B1 Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
11/20/1996 | CN1136328A Analog of haemophilus HIN47 with reduced protease activity |
11/20/1996 | CN1136281A Arteriosclerosis remedy |
11/20/1996 | CN1136280A Anti-aids secretory recombinant BCG vaccine |
11/20/1996 | CN1136043A Human interleukin-6 inhibitor |
11/20/1996 | CN1033330C Calcium channel blocking polypeptides from theraphosidae aphonopelma |
11/20/1996 | CA2175862A1 Propoxyphene derivatives for immunoassay reagents |
11/19/1996 | US5576423 Antibodies to the slam protein expressed on activated T cells |
11/19/1996 | US5576422 MCC protein and antibody |
11/19/1996 | US5576421 Recombinant chimeric HIV-1 Gag-Env fusion proteins |
11/19/1996 | US5576420 Subtilin variant of enhanced stability and activity |
11/19/1996 | US5576419 Mild solid-phase synthesis of aligned branched triple-helical peptides |
11/19/1996 | US5576301 Low molecular growth potentiating peptides |
11/19/1996 | US5576300 Method for inhibition of human rotavirus infection |
11/19/1996 | US5576297 Embodiments of natural and synthetic lethal toxin neutralizing factors and their utility as treatment for envenomation |
11/19/1996 | US5576296 Galanin antagonist |
11/19/1996 | US5576295 Agent for suppressing the motor activity of gastrointestinal tracts |
11/19/1996 | US5576294 Polypeptides as enzyme inhibitors |
11/19/1996 | US5576292 Biologically active bactericidal/permeability-increasing protein fragments |
11/19/1996 | US5576290 Compositions and methods for the diagnosis and treatment of psychogenic erectile dysfunction |
11/19/1996 | US5576210 Mammalian/yeast hybrid G protein-coupled receptors |
11/19/1996 | US5576208 Antisense oligonucleotide inhibition of the RAS gene |
11/19/1996 | US5576206 Human papilloma virus genes and their use in gene therapy |
11/19/1996 | US5576205 Kainate-binding human CNS receptors of the EAA1 family |
11/19/1996 | US5576203 Plants, seeds and process for storage of protein |
11/19/1996 | US5576202 Potato transformed with dna encoding p1 protein of potato virus y |
11/19/1996 | US5576201 Retroviral vector particles for transducing non-proliferating cells |
11/19/1996 | US5576195 Dna coding; preparing immunoglobulins |
11/19/1996 | US5576194 Recombinant protein production |
11/19/1996 | US5576193 Protein having human plasmin inhibiting activity |
11/19/1996 | US5576192 Prostaglandin E receptors, their DNA and production |
11/19/1996 | US5576191 Cytokine that binds ST2 |
11/19/1996 | US5576190 Bacteriophage Lambda pL promoters |
11/19/1996 | US5576189 Antibody to type-I collagen amino-terminal telopeptide |
11/19/1996 | US5576179 Method of detecting toxin-insensitive urf13-T protein |
11/19/1996 | US5576175 Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen |
11/19/1996 | US5576000 Envelope protein of hiv with sequences |
11/19/1996 | CA2096315C Human rotaviruses, vaccines and methods |
11/14/1996 | WO1996035955A1 Method of diagnosing prostate cancer |
11/14/1996 | WO1996035951A1 Novel peptides and compositions which modulate apoptosis |
11/14/1996 | WO1996035813A1 A transition in transcriptional activation by intracellular hormone receptors at the tumor stage of dermal fibrosarcoma development |
11/14/1996 | WO1996035808A1 Methods for detection and therapy of squamous cell carcinoma and bladder carcinoma, in particular for determining the presence and treatment of minimal residual disease, micrometastases or dissemination of such carcinoma types |
11/14/1996 | WO1996035804A1 A novel biochemical interaction in bacteria |
11/14/1996 | WO1996035797A1 Hbv vectors and cells for producing the same |
11/14/1996 | WO1996035790A1 Plant pathogen resistance genes and uses thereof |
11/14/1996 | WO1996035789A1 Human interferon tau compositions and methods of use |
11/14/1996 | WO1996035788A2 Kunitz type protease inhibitors |
11/14/1996 | WO1996035787A1 Nucleic acids for treating obesity |
11/14/1996 | WO1996035786A1 Pearl protein (nacrein) and process for producing the same |
11/14/1996 | WO1996035785A2 Transgenic animals having a defective thyroid hormone receptor beta gene |
11/14/1996 | WO1996035784A2 Chromatin-regulator genes |
11/14/1996 | WO1996035783A1 Methods of preparing soluble, oligomeric proteins |
11/14/1996 | WO1996035782A1 Il-6 activity inhibitor |